1. Home
  2. PBHC vs NTHI Comparison

PBHC vs NTHI Comparison

Compare PBHC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$16.27

Market Cap

99.5M

Sector

Finance

ML Signal

N/A

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$4.23

Market Cap

109.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBHC
NTHI
Founded
1859
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.5M
109.5M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
PBHC
NTHI
Price
$16.27
$4.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
4.6K
180.6K
Earning Date
04-29-2026
05-19-2026
Dividend Yield
2.94%
N/A
EPS Growth
46.25
N/A
EPS
0.47
N/A
Revenue
N/A
$39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$3.01
52 Week High
$17.40
$12.99

Technical Indicators

Market Signals
Indicator
PBHC
NTHI
Relative Strength Index (RSI) 54.35 54.63
Support Level $15.50 $3.01
Resistance Level $17.14 $4.59
Average True Range (ATR) 0.34 0.44
MACD -0.03 0.10
Stochastic Oscillator 45.71 58.70

Price Performance

Historical Comparison
PBHC
NTHI

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: